Advertisement

Urolithiasis pp 213-214 | Cite as

Deficit of Inhibitors and Renal Lithiasis

  • A. Conte
  • F. Grases
  • P. Roca
  • C. Genestar
  • F. J. Ruiz-Marcellan

Abstract

In calcium urolithiasis, inhibitors have a significant role to play in reducing the crystallization processes (1). Some urinary inhibitors which include magnesium, pyrophosphate, citrate, and glycosaminoglycans have been determined in a group of patients with calcium-oxalate (CaOx) urolithiasis and in a control group of healthy subjects in order to detect any possible differences between the two groups of individuals.

Keywords

Healthy Subject Uric Acid Crystallization Process Orthophosphate Concentration Heterogeneous Nucleation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    WG Robertson, AB Latif, DS Scurr, AM Caswell, GW Drach, and AD Randolph, Inhibitors of calcium oxalate crystallization in urine from stone formers and normals, in: “Urinary Stone”, R Ryall, JG Brockis, V Marshall, and B Finlayson, eds., Churchill Livingstone, Melbourne (1984).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • A. Conte
    • 1
    • 2
  • F. Grases
    • 1
    • 2
  • P. Roca
    • 1
    • 2
  • C. Genestar
    • 1
    • 2
  • F. J. Ruiz-Marcellan
    • 1
    • 2
  1. 1.Department of ChemistryUniversity of Illes BalearsPalma de MallorcaSpain
  2. 2.Urology ServiceHospital Son DuretaPalma de MallorcaSpain

Personalised recommendations